Cylex's Series C Round

Cylex raised a round of funding on March 19, 2007.

Cylex is a global life science company that develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. ImmuKnow is a non…

Articles about Cylex's Series C Round: